{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:29:26Z","timestamp":1785781766933,"version":"3.56.0"},"reference-count":214,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100006087","name":"Programa de Becas Posdoctorales of UNAM (DGAPA), PAPIIT","doi-asserted-by":"publisher","award":["IN223417"],"award-info":[{"award-number":["IN223417"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Thioredoxin1 (Trx1) is a ubiquitous antioxidant protein that regulates the cell's redox status.\nTrx1's thiol redox activity protects neurons from various physiological processes that cause\nneuronal damage and neurodegeneration, including oxidative stress, apoptosis, and inflammation.\nSeveral studies have found that direct or indirect Trx1 regulation has neuroprotective effects in the\nbrain, protecting against, preventing, or delaying neurodegenerative processes or brain traumas.\nThis review focuses on the term neuroprotection, Trx1 localization, and expression in the brain, as\nwell as its modulation concerning its neuroprotective effect in both animal and clinical models of ischemia,\nhypoxia, hemorrhage, traumatic brain injury, epilepsy, Alzheimer's disease, and Parkinson's\ndisease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205020666230809145041","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T04:33:16Z","timestamp":1691641996000},"page":"318-340","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuroprotection of Thioredoxin1 in the Brain"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-569X","authenticated-orcid":true,"given":"Roxana","family":"Noriega-Navarro","sequence":"first","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, C.P.: 04510, Ciudad\nde M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3460-7065","authenticated-orcid":true,"given":"Ricardo J.","family":"Mart\u00ednez-Tapia","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, C.P.: 04510, Ciudad\nde M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan L.","family":"Osornio-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, C.P.: 04510, Ciudad\nde M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Landa-Navarro","sequence":"additional","affiliation":[{"name":"Simons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University\nof Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis O.","family":"Xinastle-Castillo","sequence":"additional","affiliation":[{"name":"Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad\nNacional Aut\u00f3noma de M\u00e9xico, C.P. 04510, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2573-1806","authenticated-orcid":true,"given":"Abraham","family":"Landa","sequence":"additional","affiliation":[{"name":"Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad\nNacional Aut\u00f3noma de M\u00e9xico, C.P. 04510, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Navarro","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, C.P.: 04510, Ciudad\nde M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/ATVBAHA.112.249334","volume":"32","author":"Hadri K.E.","year":"2012","unstructured":"Hadri K.E.; Mahmood D.F.D.; Couchie D.; Jguirim-Souissi I.; Genze F.; Diderot V.; Syrovets T.; Lunov O.; Simmet T.; Rouis M.; Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis. Arterioscler Thromb Vasc Biol 2012,32(6),1445-1452","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/abbs\/gms103","volume":"45","author":"Li H.","year":"2013","unstructured":"Li H.; Wan A.; Xu G.; Ye D.; Small changes huge impact: The role of thioredoxin 1 in the regulation of apoptosis by S-nitrosylation. Acta Biochim Biophys Sin 2013,45(3),153-161","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1089\/ars.2012.4650","volume":"17","author":"Lu J.","year":"2012","unstructured":"Lu J.; Holmgren A.; Thioredoxin system in cell death progression. Antioxid Redox Signal 2012,17(12),1738-1747","journal-title":"Antioxid Redox Signal"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1182\/blood.V97.10.3184","volume":"97","author":"Pekkari K.","year":"2001","unstructured":"Pekkari K.; Avila-Cari\u00f1o J.; Bengtsson A.; Gurunath R.; Scheynius A.; Holmgren A.; Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood 2001,97(10),3184-3190","journal-title":"Blood"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/antiox9121257","volume":"9","author":"Seco-Cervera M.","year":"2020","unstructured":"Seco-Cervera M.; Gonz\u00e1lez-Cabo P.; Pallard\u00f3 F.; Rom\u00e1-Mateo C.; Garc\u00eda-Gim\u00e9nez J.; Thioredoxin and glutaredoxin systems as potential targets for the development of new treatments in Friedreich\u2019s ataxia. Antioxidants 2020,9(12),1257","journal-title":"Antioxidants"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mito.2019.04.010","volume":"47","author":"Xie W.","year":"2019","unstructured":"Xie W.; Ma W.; Liu P.; Zhou F.; Overview of thioredoxin system and targeted therapies for acute leukemia. Mitochondrion 2019,47,38-46","journal-title":"Mitochondrion"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/ars.2020.8213","volume":"34","author":"Zhang J.","year":"2021","unstructured":"Zhang J.; Duan D.; Osama A.; Fang J.; Natural molecules targeting thioredoxin system and their therapeutic potential. Antioxid Redox Signal 2021,34(14),1083-1107","journal-title":"Antioxid Redox Signal"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"e16960","DOI":"10.1371\/journal.pone.0016960","volume":"6","author":"Cortes-Bratti X.","year":"2011","unstructured":"Cortes-Bratti X.; Bass\u00e8res E.; Herrera-Rodriguez F.; Botero-Kleiven S.; Coppotelli G.; Andersen J.B.; Masucci M.G.; Holmgren A.; Chaves-Olarte E.; Frisan T.; Avila-Cari\u00f1o J.; Thioredoxin 80-activated-monocytes (TAMs) inhibit the replication of intracellular pathogens. PLoS One 2011,6(2),e16960","journal-title":"PLoS One"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/emmm.201201462","volume":"4","author":"Gil-Bea F.","year":"2012","unstructured":"Gil-Bea F.; Akterin S.; Persson T.; Mateos L.; Sandebring A.; Avila-Cari\u00f1o J.; Gutierrez-Rodriguez A.; Sundstr\u00f6m E.; Holmgren A.; Winblad B.; Cedazo-Minguez A.; Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer\u2019s disease brain. EMBO Mol Med 2012,4(10),1097-1111","journal-title":"EMBO Mol Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/molecules22020259","volume":"22","author":"Guevara-Flores A.","year":"2017","unstructured":"Guevara-Flores A.; Mart\u00ednez-Gonz\u00e1lez J.; Rend\u00f3n J.; del Arenal I.; The architecture of thiol antioxidant systems among invertebrate parasites. Molecules 2017,22(2),259","journal-title":"Molecules"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/ars.2005.7.395","volume":"7","author":"Kabe Y.","year":"2005","unstructured":"Kabe Y.; Ando K.; Hirao S.; Yoshida M.; Handa H.; Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005,7(3-4),395-403","journal-title":"Antioxid Redox Signal"},{"key":"ref=12","first-page":"6688","volume":"60","author":"Wei S.J.","year":"2000","unstructured":"Wei S.J.; Botero A.; Hirota K.; Bradbury C.M.; Markovina S.; Laszlo A.; Spitz D.R.; Goswami P.C.; Yodoi J.; Gius D.; Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 2000,60(23),6688-6695","journal-title":"Cancer Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"33242","DOI":"10.1074\/jbc.M202026200","volume":"277","author":"Chen Y.","year":"2002","unstructured":"Chen Y.; Cai J.; Murphy T.J.; Jones D.P.; Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem 2002,277(36),33242-33248","journal-title":"J Biol Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"33249","DOI":"10.1074\/jbc.M203036200","volume":"277","author":"Damdimopoulos A.E.","year":"2002","unstructured":"Damdimopoulos A.E.; Miranda-Vizuete A.; Pelto-Huikko M.; Gustafsson J.\u00c5.; Spyrou G.; Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 2002,277(36),33249-33257","journal-title":"J Biol Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1089\/ars.2010.3114","volume":"13","author":"Collet J.F.","year":"2010","unstructured":"Collet J.F.; Messens J.; Structure, function, and mechanism of thioredoxin proteins. Antioxid Redox Signal 2010,13(8),1205-1216","journal-title":"Antioxid Redox Signal"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.freeradbiomed.2014.11.021","volume":"79","author":"Kronenfeld G.","year":"2015","unstructured":"Kronenfeld G.; Engelman R.; Weisman-Shomer P.; Atlas D.; Benhar M.; Thioredoxin-mimetic peptides as catalysts of S-denitrosylation and anti-nitrosative stress agents. Free Radic Biol Med 2015,79,138-146","journal-title":"Free Radic Biol Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.4049\/jimmunol.156.2.765","volume":"156","author":"Schenk H.","year":"1996","unstructured":"Schenk H.; Vogt M.; Dr\u00f6ge W.; Schulze-Osthoff K.; Thioredoxin as a potent costimulus of cytokine expression. J Immunol 1996,156(2),765-771","journal-title":"J Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.semcancer.2006.09.003","volume":"16","author":"Fujino G.","year":"2006","unstructured":"Fujino G.; Noguchi T.; Takeda K.; Ichijo H.; Thioredoxin and protein kinases in redox signaling. Semin Cancer Biol 2006,16(6),427-435","journal-title":"Semin Cancer Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.4049\/jimmunol.1101295","volume":"188","author":"King B. C.","year":"2012","unstructured":"King B. C.; Nowakowska J.; Karsten C. M.; K\u00f6hl J.; Renstr\u00f6m E.; Blom A. M.; Truncated and full-length thioredoxin-1 have opposing activating and inhibitory properties for human complement with relevance to endothelial surfaces. J Immunol 2012,188(8),4103-12","journal-title":"J Immunol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bbrc.2018.11.069","volume":"507","author":"Kim D.O.","year":"2018","unstructured":"Kim D.O.; Byun J.E.; Seong H.A.; Yoon S.R.; Choi I.; Jung H.; Thioredoxin-interacting protein-derived peptide (TN13) inhibits LPS-induced inflammation by inhibiting p38 MAPK signaling. Biochem Biophys Res Commun 2018,507(1-4),489-495","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.freeradbiomed.2007.02.007","volume":"42","author":"Rancourt R.","year":"2007","unstructured":"Rancourt R.; Lee R.; Oneill H.; Accurso F.; White C.; Reduced thioredoxin increases proinflammatory cytokines and neutrophil influx in rat airways: Modulation by airway mucus. Free Radic Biol Med 2007,42(9),1441-1453","journal-title":"Free Radic Biol Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0378-1119(91)90081-L","volume":"102","author":"Tonissen K.F.","year":"1991","unstructured":"Tonissen K.F.; Wells J.R.E.; Isolation and characterization of human thioredoxin-encoding genes. Gene 1991,102(2),221-228","journal-title":"Gene"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"Zhou R.","year":"2010","unstructured":"Zhou R.; Tardivel A.; Thorens B.; Choi I.; Tschopp J.; Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010,11(2),136-140","journal-title":"Nat Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/jcp.24319","volume":"228","author":"Mahmood D.F.D.","year":"2013","unstructured":"Mahmood D.F.D.; Abderrazak A.; Couchie D.; Lunov O.; Diderot V.; Syrovets T.; Slimane M.N.; Gosselet F.; Simmet T.; Rouis M.; El Hadri K.; Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis. J Cell Physiol 2013,228(7),1577-1583","journal-title":"J Cell Physiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8781","DOI":"10.1073\/pnas.1805288115","volume":"115","author":"Plugis N.M.","year":"2018","unstructured":"Plugis N.M.; Weng N.; Zhao Q.; Palanski B.A.; Maecker H.T.; Habtezion A.; Khosla C.; Interleukin 4 is inactivated via selective disulfide-bond reduction by extracellular thioredoxin. Proc Natl Acad Sci USA 2018,115(35),8781-8786","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.coph.2007.04.003","volume":"7","author":"Powis G.","year":"2007","unstructured":"Powis G.; Kirkpatrick D.L.; Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol 2007,7(4),392-397","journal-title":"Curr Opin Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0076-6879(10)74005-2","volume":"474","author":"Yoshihara E.","year":"2010","unstructured":"Yoshihara E.; Chen Z.; Matsuo Y.; Masutani H.; Yodoi J.; Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling. Methods Enzymol 2010,474,67-82","journal-title":"Methods Enzymol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/mas.21430","volume":"34","author":"Kim H.J.","year":"2015","unstructured":"Kim H.J.; Ha S.; Lee H.Y.; Lee K.J.; ROSics: Chemistry and proteomics of cysteine modifications in redox biology. Mass Spectrom Rev 2015,34(2),184-208","journal-title":"Mass Spectrom Rev"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1385\/MN:29:3:229","volume":"29","author":"Masutani H.","year":"2004","unstructured":"Masutani H.; Bai J.; Kim Y.C.; Yodoi J.; Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Mol Neurobiol 2004,29(3),229-242","journal-title":"Mol Neurobiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.pharmtox.41.1.261","volume":"41","author":"Powis G.","year":"2001","unstructured":"Powis G.; Montfort W.R.; Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 2001,41(1),261-295","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0891-5849(00)00313-0","volume":"29","author":"Powis G.","year":"2000","unstructured":"Powis G.; Mustacich D.; Coon A.; The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 2000,29(3-4),312-322","journal-title":"Free Radic Biol Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8421597","volume":"2016","author":"Ditgen D.","year":"2016","unstructured":"Ditgen D.; Anandarajah E.M.; Hansmann J.; Winter D.; Schramm G.; Erttmann K.D.; Liebau E.; Brattig N.W.; Multifunctional thioredoxin-like protein from the gastrointestinal parasitic nematodes Strongyloides ratti and Trichuris suis affects mucosal homeostasis. J Parasitol Res 2016,2016,1-17","journal-title":"J Parasitol Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","volume":"66","author":"Lu J.","year":"2014","unstructured":"Lu J.; Holmgren A.; The thioredoxin antioxidant system. Free Radic Biol Med 2014,66,75-87","journal-title":"Free Radic Biol Med"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0969-2126(01)00154-X","volume":"3","author":"Martin J. L.","year":"1995","unstructured":"Martin J. L.; Thioredoxin\u2014A fold for all reasons. Structure 1995,3(3),245-50","journal-title":"Structure"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1074\/mcp.M800580-MCP200","volume":"8","author":"Fu C.","year":"2009","unstructured":"Fu C.; Wu C.; Liu T.; Ago T.; Zhai P.; Sadoshima J.; Li H.; Elucidation of thioredoxin target protein networks in mouse. Mol Cell Proteomics 2009,8(7),1674-1687","journal-title":"Mol Cell Proteomics"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/nar\/24.14.2746","volume":"24","author":"Taniguchi Y.","year":"1996","unstructured":"Taniguchi Y.; Taniguchi-Ueda Y.; Mori K.; Yodoi J.; A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)\/human thioredoxin (Trx) gene. Nucleic Acids Res 1996,24(14),2746-2752","journal-title":"Nucleic Acids Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1089\/ars.2016.6925","volume":"27","author":"Ren X.","year":"2017","unstructured":"Ren X.; Zou L.; Zhang X.; Branco V.; Wang J.; Carvalho C.; Holmgren A.; Lu J.; Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system. Antioxid Redox Signal 2017,27(13),989-1010","journal-title":"Antioxid Redox Signal"},{"key":"ref=38","first-page":"79","volume":"38","author":"Rozell B.","year":"1985","unstructured":"Rozell B.; Hansson H.A.; Luthman M.; Holmgren A.; Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 1985,38(1),79-86","journal-title":"Eur J Cell Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/0192623310389621","volume":"39","author":"Garman R.H.","year":"2011","unstructured":"Garman R.H.; Histology of the central nervous system. Toxicol Pathol 2011,39(1),22-35","journal-title":"Toxicol Pathol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0006-8993(94)90241-0","volume":"652","author":"Hori K.","year":"1994","unstructured":"Hori K.; Katayama M.; Sato N.; Ishii K.; Waga S.; Yodoi J.; Neuroprotection by glial cells through adult T cell leukemia-derived factor\/human thioredoxin (ADF\/TRX). Brain Res 1994,652(2),304-310","journal-title":"Brain Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.3892\/mmr.2016.4855","volume":"13","author":"Wang M.","year":"2016","unstructured":"Wang M.; Zhu K.; Zhang L.; Li L.; Zhao J.; Thioredoxin 1 protects astrocytes from oxidative stress by maintaining peroxiredoxin activity. Mol Med Rep 2016,13(3),2864-2870","journal-title":"Mol Med Rep"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainresbull.2007.01.016","volume":"73","author":"Sharma V.","year":"2007","unstructured":"Sharma V.; Mishra M.; Ghosh S.; Tewari R.; Basu A.; Seth P.; Sen E.; Modulation of interleukin-1\u03b2 mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection. Brain Res Bull 2007,73(1-3),55-63","journal-title":"Brain Res Bull"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.4049\/jimmunol.181.10.7254","volume":"181","author":"Jana M.","year":"2008","unstructured":"Jana M.; Palencia C.A.; Pahan K.; Fibrillar amyloid-\u03b2 peptides activate microglia via TLR2: Implications for Alzheimer\u2019s disease. J Immunol 2008,181(10),7254-7262","journal-title":"J Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fncel.2018.00215","volume":"12","author":"Lively S.","year":"2018","unstructured":"Lively S.; Schlichter L.C.; Microglia responses to pro-inflammatory stimuli (LPS, IFN\u03b3+TNF\u03b1) and reprogramming by resolving cytokines (IL-4, IL-10). Front Cell Neurosci 2018,12,215","journal-title":"Front Cell Neurosci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12974-016-0621-8","volume":"13","author":"Monif M.","year":"2016","unstructured":"Monif M.; Reid C.A.; Powell K.L.; Drummond K.J.; O\u2019Brien T.J.; Williams D.A.; Interleukin-1\u03b2 has trophic effects in microglia and its release is mediated by P2X7R pore. J Neuroinflammation 2016,13(1),173","journal-title":"J Neuroinflammation"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.cdd.4401818","volume":"13","author":"Akterin S.","year":"2006","unstructured":"Akterin S.; Cowburn R.F.; Miranda-Vizuete A.; Jim\u00e9nez A.; Bogdanovic N.; Winblad B.; Cedazo-Minguez A.; Involvement of glutaredoxin-1 and thioredoxin-1 in \u03b2-amyloid toxicity and Alzheimer\u2019s disease. Cell Death Differ 2006,13(9),1454-1465","journal-title":"Cell Death Differ"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"12157","DOI":"10.1073\/pnas.1401712111","volume":"111","author":"Salzano S.","year":"2014","unstructured":"Salzano S.; Checconi P.; Hanschmann E.M.; Lillig C.H.; Bowler L.D.; Chan P.; Vaudry D.; Mengozzi M.; Coppo L.; Sacre S.; Atkuri K.R.; Sahaf B.; Herzenberg L.A.; Herzenberg L.A.; Mullen L.; Ghezzi P.; Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proc Natl Acad Sci USA 2014,111(33),12157-12162","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=48","author":"Ariff-Iqbal M.","year":"2016","unstructured":"Ariff-Iqbal M.; Role of thioredoxin system in regulation of neural stem cell proliferation and differentiation. University of Manitoba Winnipeg. 2016"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Zhang Y.","year":"2014","unstructured":"Zhang Y.; Chen K.; Sloan S.A.; Bennett M.L.; Scholze A.R.; O\u2019Keeffe S.; Phatnani H.P.; Guarnieri P.; Caneda C.; Ruderisch N.; Deng S.; Liddelow S.A.; Zhang C.; Daneman R.; Maniatis T.; Barres B.A.; Wu J.Q.; An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 2014,34(36),11929-11947","journal-title":"J Neurosci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/bph.13426","volume":"174","author":"Vilhardt F.","year":"2017","unstructured":"Vilhardt F.; Haslund-Vinding J.; Jaquet V.; McBean G.; Microglia antioxidant systems and redox signalling. Br J Pharmacol 2017,174(12),1719-1732","journal-title":"Br J Pharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbagen.2010.05.006","volume":"1810","author":"Godoy J.R.","year":"2011","unstructured":"Godoy J.R.; Funke M.; Ackermann W.; Haunhorst P.; Oesteritz S.; Capani F.; Els\u00e4sser H.P.; Lillig C.H.; Redox atlas of the mouse. Biochim Biophys Acta, Gen Subj 2011,1810(1),2-92","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbagen.2010.06.011","volume":"1810","author":"Aon-Bertolino M.L.","year":"2011","unstructured":"Aon-Bertolino M.L.; Romero J.I.; Galeano P.; Holubiec M.; Badorrey M.S.; Saraceno G.E.; Hanschmann E.M.; Lillig C.H.; Capani F.; Thioredoxin and glutaredoxin system proteins-immunolocalization in the rat central nervous system. Biochim Biophys Acta, Gen Subj 2011,1810(1),93-110","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1089\/ars.2016.6706","volume":"27","author":"Yin B.","year":"2017","unstructured":"Yin B.; Barrionuevo G.; Batinic-Haberle I.; Sandberg M.; Weber S.G.; Differences in reperfusion-induced mitochondrial oxidative stress and cell death between hippocampal CA1 and CA3 subfields are due to the mitochondrial thioredoxin system. Antioxid Redox Signal 2017,27(9),534-549","journal-title":"Antioxid Redox Signal"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.celrep.2014.08.017","volume":"8","author":"Pirazzini M.","year":"2014","unstructured":"Pirazzini M.; Azarnia Tehran D.; Zanetti G.; Megighian A.; Scorzeto M.; Fillo S.; Shone C.C.; Binz T.; Rossetto O.; Lista F.; Montecucco C.; Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins. Cell Rep 2014,8(6),1870-1878","journal-title":"Cell Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/590808","volume":"2014","author":"Silva-Adaya D.","year":"2014","unstructured":"Silva-Adaya D.; Gonsebatt M.E.; Guevara J.; Thioredoxin system regulation in the central nervous system: Experimental models and clinical evidence. Oxid Med Cell Longev 2014,2014,1-13","journal-title":"Oxid Med Cell Longev"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1054\/jocn.2001.1027","volume":"9","author":"Vajda F.J.E.","year":"2002","unstructured":"Vajda F.J.E.; Neuroprotection and neurodegenerative disease. J Clin Neurosci 2002,9(1),4-8","journal-title":"J Clin Neurosci"},{"key":"ref=57","author":"Farooqui A.A.","year":"2021","unstructured":"Farooqui A.A.;  Neuroinflammation, resolution, and neuroprotection in the brain 2021","journal-title":"Neuroinflammation, resolution, and neuroprotection in the brain"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0166-2236(03)00071-7","volume":"26","author":"Dirnagl U.","year":"2003","unstructured":"Dirnagl U.; Simon R.P.; Hallenbeck J.M.; Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003,26(5),248-254","journal-title":"Trends Neurosci"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9465-6","author":"Jain K.K.","year":"2019","unstructured":"Jain K.K.;  The Handbook of Neuroprotection 2019","journal-title":"The Handbook of Neuroprotection"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/cells10020370","volume":"10","author":"Marmolejo-Mart\u00ednez-Artesero S.","year":"2021","unstructured":"Marmolejo-Mart\u00ednez-Artesero S.; Casas C.; Romeo-Guitart D.; Endogenous mechanisms of neuroprotection: To boost or not to be. Cells 2021,10(2),370","journal-title":"Cells"},{"key":"ref=61","first-page":"247","volume":"32","author":"Smirnova L.","year":"2015","unstructured":"Smirnova L.; Harris G.; Leist M.; Hartung T.; Cellular resilience. Altern Anim Exp 2015,32(4),247-260","journal-title":"Altern Anim Exp"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.thromres.2008.11.004","volume":"123","author":"Jia J.","year":"2009","unstructured":"Jia J.; Zhang X.; Hu Y.S.; Wu Y.; Wang Q.Z.; Li N.N.; Wu C.Q.; Yu H.X.; Guo Q.C.; Protective effect of tetraethyl pyrazine against focal cerebral ischemia\/reperfusion injury in rats: Therapeutic time window and its mechanism. Thromb Res 2009,123(5),727-730","journal-title":"Thromb Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12035-014-9016-y","volume":"53","author":"Wu M.H.","year":"2016","unstructured":"Wu M.H.; Song F.Y.; Wei L.P.; Meng Z.Y.; Zhang Z.Q.; Qi Q.D.; Serum levels of thioredoxin are associated with stroke risk, severity, and lesion volumes. Mol Neurobiol 2016,53(1),677-685","journal-title":"Mol Neurobiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3892\/etm.2014.1936","volume":"8","author":"Tang Q.","year":"2014","unstructured":"Tang Q.; Han R.; Xiao H.; Li J.; Shen J.; Luo Q.; Protective effect of tanshinone IIA on the brain and its therapeutic time window in rat models of cerebral ischemia-reperfusion. Exp Ther Med 2014,8(5),1616-1622","journal-title":"Exp Ther Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000354583","volume":"92","author":"Chi O.Z.","year":"2013","unstructured":"Chi O.Z.; Barsoum S.; Grayson J.; Liu X.; Weiss H.R.; Effects of the thioredoxin-1 inhibitor PX-12 on blood-brain barrier permeability in the early stage of focal cerebral ischemia. Pharmacology 2013,92(3-4),175-181","journal-title":"Pharmacology"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neuroscience.2018.03.029","volume":"379","author":"Zhu W.","year":"2018","unstructured":"Zhu W.; Wang X.R.; Du S.Q.; Yan C.Q.; Yang N.N.; Lin L.L.; Shi G.X.; Liu C.Z.; Anti-oxidative and anti-apoptotic effects of acupuncture: Role of thioredoxin-1 in the hippocampus of vascular dementia rats. Neuroscience 2018,379,281-291","journal-title":"Neuroscience"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neuropharm.2013.10.027","volume":"77","author":"Tian L.","year":"2014","unstructured":"Tian L.; Nie H.; Zhang Y.; Chen Y.; Peng Z.; Cai M.; Wei H.; Qin P.; Dong H.; Xiong L.; Recombinant human thioredoxin-1 promotes neurogenesis and facilitates cognitive recovery following cerebral ischemia in mice. Neuropharmacology 2014,77,453-464","journal-title":"Neuropharmacology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/01616412.2017.1359882","volume":"39","author":"Yu T.","year":"2017","unstructured":"Yu T.; Zhang W.; Lin Y.; Li Q.; Xue J.; Cai Z.; Cheng Y.; Shao B.; Prognostic value of serum thioredoxin levels in ischemic stroke. Neurol Res 2017,39(11),988-995","journal-title":"Neurol Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1089\/ars.2011.4298","volume":"17","author":"Gan Y.","year":"2012","unstructured":"Gan Y.; Ji X.; Hu X.; Luo Y.; Zhang L.; Li P.; Liu X.; Yan F.; Vosler P.; Gao Y.; Stetler R.A.; Chen J.; Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive pro-death signaling pathway. Antioxid Redox Signal 2012,17(5),719-732","journal-title":"Antioxid Redox Signal"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4103\/1673-5374.153700","volume":"10","author":"Zhao J.","year":"2015","unstructured":"Zhao J.; Wu J.; Zhang L.; Chen Y.; Yu S.; Zhao Y.; Curcumin pretreatment and post-treatment both improve the antioxidative ability of neurons with oxygen-glucose deprivation. Neural Regen Res 2015,10(3),481-489","journal-title":"Neural Regen Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(98)00492-3","volume":"251","author":"Takagi Y.","year":"1998","unstructured":"Takagi Y.; Horikawa F.; Nozaki K.; Sugino T.; Hashimoto N.; Yodoi J.; Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci Lett 1998,251(1),25-28","journal-title":"Neurosci Lett"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00004647-199802000-00012","volume":"18","author":"Takagi Y.","year":"1998","unstructured":"Takagi Y.; Tokime T.; Nozaki K.; Gon Y.; Kikuchi H.; Yodoi J.; Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: Immunohistochemical and hybridization studies of thioredoxin. J Cereb Blood Flow Metab 1998,18(2),206-214","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12871-018-0636-z","volume":"18","author":"Wang S.","year":"2018","unstructured":"Wang S.; Li Y.; Wei J.; Li P.; Yang Q.; Sevoflurane preconditioning induces tolerance to brain ischemia partially via inhibiting thioredoxin-1 nitration. BMC Anesthesiol 2018,18(1),171","journal-title":"BMC Anesthesiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bbagen.2015.02.015","volume":"1850","author":"Romero J.I.","year":"2015","unstructured":"Romero J.I.; Hanschmann E.M.; Gellert M.; Eitner S.; Holubiec M.I.; Blanco-Calvo E.; Lillig C.H.; Capani F.; Thioredoxin 1 and glutaredoxin 2 contribute to maintain the phenotype and integrity of neurons following perinatal asphyxia. Biochim Biophys Acta, Gen Subj 2015,1850(6),1274-1285","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.12.021","volume":"80","author":"Qi A.","year":"2015","unstructured":"Qi A.; Li Y.; Liu Q.; Si J.Z.; Tang X.M.; Zhang Z.Q.; Qi Q.D.; Chen W.B.; Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke. Free Radic Biol Med 2015,80,129-135","journal-title":"Free Radic Biol Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(93)90130-F","volume":"625","author":"Tomimoto H.","year":"1993","unstructured":"Tomimoto H.; Akiguchi I.; Wakita H.; Kimura J.; Hori K.; Yodoi J.; Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res 1993,625(1),1-8","journal-title":"Brain Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1139\/cjpp-2013-0274","volume":"92","author":"Zeng X.S.","year":"2014","unstructured":"Zeng X.S.; Zhou X.S.; Luo F.C.; Jia J.J.; Qi L.; Yang Z.X.; Zhang W.; Bai J.; Comparative analysis of the neuroprotective effects of ginsenosides Rg1 and Rb1 extracted from Panax notoginseng against cerebral ischemia. Can J Physiol Pharmacol 2014,92(2),102-108","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.brainres.2010.11.010","volume":"1370","author":"Tanaka N.","year":"2011","unstructured":"Tanaka N.; Ikeda Y.; Ohta Y.; Deguchi K.; Tian F.; Shang J.; Matsuura T.; Abe K.; Expression of Keap1\u2013Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion. Brain Res 2011,1370,246-253","journal-title":"Brain Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1161\/STROKEAHA.114.006135","volume":"45","author":"Zhao H.","year":"2014","unstructured":"Zhao H.; Wang R.; Tao Z.; Gao L.; Yan F.; Gao Z.; Liu X.; Ji X.; Luo Y.; Ischemic postconditioning relieves cerebral ischemia and reperfusion injury through activating T-LAK cell-originated protein kinase\/protein kinase B pathway in rats. Stroke 2014,45(8),2417-2424","journal-title":"Stroke"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1292\/jvms.09-0364","volume":"72","author":"Koh P.O.","year":"2010","unstructured":"Koh P.O.; Proteomic analysis of focal cerebral ischemic injury in male rats. J Vet Med Sci 2010,72(2),181-185","journal-title":"J Vet Med Sci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0304-3940(00)00936-8","volume":"284","author":"Yamagata K.","year":"2000","unstructured":"Yamagata K.; Tagami M.; Ikeda K.; Yamori Y.; Nara Y.; Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Neurosci Lett 2000,284(3),131-134","journal-title":"Neurosci Lett"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.neuroscience.2014.10.066","volume":"284","author":"Li L.","year":"2015","unstructured":"Li L.; Zhu K.; Liu Y.; Wu X.; Wu J.; Zhao Y.; Zhao J.; Targeting thioredoxin-1 with siRNA exacerbates oxidative stress injury after cerebral ischemia\/reperfusion in rats. Neuroscience 2015,284,815-823","journal-title":"Neuroscience"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainres.2014.12.033","volume":"1599","author":"Wu X.","year":"2015","unstructured":"Wu X.; Li L.; Zhang L.; Wu J.; Zhou Y.; Zhou Y.; Zhao Y.; Zhao J.; Inhibition of thioredoxin-1 with siRNA exacerbates apoptosis by activating the ASK1-JNK\/p38 pathway in brain of a stroke model rats. Brain Res 2015,1599,20-31","journal-title":"Brain Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2017.06.027","volume":"336","author":"Hou Y.","year":"2018","unstructured":"Hou Y.; Wang Y.; He Q.; Li L.; Xie H.; Zhao Y.; Zhao J.; Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1\/TXNIP complex in cerebral ischemia reperfusion injury. Behav Brain Res 2018,336,32-39","journal-title":"Behav Brain Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1073\/pnas.96.7.4131","volume":"96","author":"Takagi Y.","year":"1999","unstructured":"Takagi Y.; Mitsui A.; Nishiyama A.; Nozaki K.; Sono H.; Gon Y.; Hashimoto N.; Yodoi J.; Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 1999,96(7),4131-4136","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainres.2009.03.023","volume":"1272","author":"Zhou F.","year":"2009","unstructured":"Zhou F.; Gomi M.; Fujimoto M.; Hayase M.; Marumo T.; Masutani H.; Yodoi J.; Hashimoto N.; Nozaki K.; Takagi Y.; Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia. Brain Res 2009,1272,62-70","journal-title":"Brain Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/152308604771978372","volume":"6","author":"Hattori I.","year":"2004","unstructured":"Hattori I.; Takagi Y.; Nakamura H.; Nozaki K.; Bai J.; Kondo N.; Sugino T.; Nishimura M.; Hashimoto N.; Yodoi J.; Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal 2004,6(1),81-87","journal-title":"Antioxid Redox Signal"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.neuint.2012.01.029","volume":"60","author":"Ma Y.H.","year":"2012","unstructured":"Ma Y.H.; Su N.; Chao X.D.; Zhang Y.Q.; Zhang L.; Han F.; Luo P.; Fei Z.; Qu Y.; Thioredoxin-1 attenuates post-ischemic neuronal apoptosis via reducing oxidative\/nitrative stress. Neurochem Int 2012,60(5),475-483","journal-title":"Neurochem Int"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuroscience.2019.11.043","volume":"428","author":"Park D.J.","year":"2020","unstructured":"Park D.J.; Kang J.B.; Shah F.A.; Jin Y.B.; Koh P.O.; Quercetin attenuates decrease of thioredoxin expression following focal cerebral ischemia and glutamate-induced neuronal cell damage. Neuroscience 2020,428,38-49","journal-title":"Neuroscience"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"12585","DOI":"10.1111\/jcmm.15820","volume":"24","author":"Jiao Y.","year":"2020","unstructured":"Jiao Y.; Wang J.; Zhang H.; Cao Y.; Qu Y.; Huang S.; Kong X.; Song C.; Li J.; Li Q.; Ma H.; Lu X.; Wang L.; Inhibition of microglial receptor-interacting protein kinase 1 ameliorates neuroinflammation following cerebral ischaemic stroke. J Cell Mol Med 2020,24(21),12585-12598","journal-title":"J Cell Mol Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainres.2015.04.033","volume":"1615","author":"Wang B.","year":"2015","unstructured":"Wang B.; Tian S.; Wang J.; Han F.; Zhao L.; Wang R.; Ning W.; Chen W.; Qu Y.; Intraperitoneal administration of thioredoxin decreases brain damage from ischemic stroke. Brain Res 2015,1615,89-97","journal-title":"Brain Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/cns.12051","volume":"19","author":"Zhou F.","year":"2013","unstructured":"Zhou F.; Liu P.P.; Ying G.Y.; Zhu X.D.; Shen H.; Chen G.; Effects of thioredoxin-1 on neurogenesis after brain ischemia\/reperfusion injury. CNS Neurosci Ther 2013,19(3),204-205","journal-title":"CNS Neurosci Ther"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/ALN.0000000000001485","volume":"126","author":"Cai M.","year":"2017","unstructured":"Cai M.; Tong L.; Dong B.; Hou W.; Shi L.; Dong H.; Kelch-like ECH-associated protein 1-dependent nuclear factor-E2\u2013related factor 2 activation in relation to antioxidation induced by sevoflurane preconditioning. Anesthesiology 2017,126(3),507-521","journal-title":"Anesthesiology"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s11064-021-03403-0","volume":"46","author":"Park D.J.","year":"2021","unstructured":"Park D.J.; Kang J.B.; Shah M.A.; Koh P.O.; Epigallocatechin gallate alleviates down-regulation of thioredoxin in ischemic brain damage and glutamate-exposed neuron. Neurochem Res 2021,46(11),3035-3049","journal-title":"Neurochem Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neulet.2014.02.040","volume":"566","author":"Sung J.H.","year":"2014","unstructured":"Sung J.H.; Gim S.A.; Koh P.O.; Ferulic acid attenuates the cerebral ischemic injury-induced decrease in peroxiredoxin-2 and thioredoxin expression. Neurosci Lett 2014,566,88-92","journal-title":"Neurosci Lett"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1111\/jcmm.15099","volume":"24","author":"Zhang J.","year":"2020","unstructured":"Zhang J.; Zhou R.; Xiang C.; Fan F.; Gao J.; Zhang Y.; Tang S.; Xu H.; Yang H.; Enhanced thioredoxin, glutathione and Nrf2 antioxidant systems by safflower extract and aceglutamide attenuate cerebral ischaemia\/reperfusion injury. J Cell Mol Med 2020,24(9),4967-4980","journal-title":"J Cell Mol Med"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2008.09.007","volume":"449","author":"Zhu X.-L.","year":"2009","unstructured":"Zhu X.-L.; Xiong L.-Z.; Wang Q.; Liu Z.-G.; Ma X.; Zhu Z.-H.; Hu S.; Gong G.; Chen S.-Y.; Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia\/reperfusion injury in rats. Neurosci Lett 2009,449(1),24-7","journal-title":"Neurosci Lett"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fnins.2018.00888","volume":"12","author":"Shah F.A.","year":"2018","unstructured":"Shah F.A.; Zeb A.; Ali T.; Muhammad T.; Faheem M.; Alam S.I.; Saeed K.; Koh P.O.; Lee K.W.; Kim M.O.; Identification of proteins differentially expressed in the striatum by melatonin in a middle cerebral artery occlusion rat model\u2014a proteomic and in silico approach. Front Neurosci 2018,12,888","journal-title":"Front Neurosci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1600-079X.2008.00661.x","volume":"46","author":"Sung J.H.","year":"2009","unstructured":"Sung J.H.; Cho E.H.; Kim M.O.; Koh P.O.; Identification of proteins differentially expressed by melatonin treatment in cerebral ischemic injury - a proteomics approach. J Pineal Res 2009,46(3),300-306","journal-title":"J Pineal Res"},{"key":"ref=100","first-page":"3493","volume":"22","author":"Zhang L-L.","year":"2018","unstructured":"Zhang L-L.; Zhang Z-J.; Sestrin2 aggravates oxidative stress of neurons by decreasing the expression of Nrf2. Eur Rev Med Pharmacol Sci 2018,22(11),3493-3501","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3892\/etm.2018.6456","volume":"16","author":"Guo Y.D.","year":"2018","unstructured":"Guo Y.D.; Huang T.; Sheng W.H.; Guan Y.F.; Du Y.F.; Lin Y.T.; Ruan X.Y.; Neuroprotective effect of recombinant adeno-associated virus human thioredoxin-PR39 on acute cerebral infarction in rats. Exp Ther Med 2018,16(3),2633-2638","journal-title":"Exp Ther Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4062\/biomolther.2020.154","volume":"29","author":"Yeo E.J.","year":"2021","unstructured":"Yeo E.J.; Eum W.S.; Yeo H.J.; Choi Y.J.; Sohn E.J.; Kwon H.J.; Kim D.W.; Kim D.S.; Cho S.W.; Park J.; Han K.H.; Lee K.W.; Park J.K.; Shin M.J.; Choi S.Y.; Protective role of transduced tat-thioredoxin1 (Trx1) against oxidative stress-induced neuronal cell death via ASK1-MAPK signal pathway. Biomol Ther 2021,29(3),321-330","journal-title":"Biomol Ther"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.lfs.2004.10.069","volume":"77","author":"Siu F.K.W.","year":"2005","unstructured":"Siu F.K.W.; Lo S.C.L.; Leung M.C.P.; Electro-acupuncture potentiates the disulphide-reducing activities of thioredoxin system by increasing thioredoxin expression in ischemia-reperfused rat brains. Life Sci 2005,77(4),386-399","journal-title":"Life Sci"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1179\/135100002125000749","volume":"7","author":"Hattori I.","year":"2002","unstructured":"Hattori I.; Takagi Y.; Nozaki K.; Kondo N.; Bai J.; Nakamura H.; Hashimoto N.; Yodoi J.; Hypoxia-ischemia induces thioredoxin expression and nitrotyrosine formation in new-born rat brain. Redox Rep 2002,7(5),256-259","journal-title":"Redox Rep"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.neuroscience.2009.02.086","volume":"161","author":"Barhwal K.","year":"2009","unstructured":"Barhwal K.; Hota S.K.; Jain V.; Prasad D.; Singh S.B.; Ilavazhagan G.; Acetyl-l-carnitine (ALCAR) prevents hypobaric hypoxia\u2013induced spatial memory impairment through extracellular related kinase\u2013mediated nuclear factor erythroid 2-related factor 2 phosphorylation. Neuroscience 2009,161(2),501-514","journal-title":"Neuroscience"},{"key":"ref=106","first-page":"3074","volume":"125","author":"Yang X-H.","year":"2012","unstructured":"Yang X-H.; Liu H-G.; Liu X.; Chen J-N.; Thioredoxin and impaired spatial learning and memory in the rats exposed to intermittent hypoxia. Chin Med J (Engl) 2012,125(17),3074-3080","journal-title":"Chin Med J (Engl)"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neulet.2004.08.022","volume":"370","author":"Stroev S.A.","year":"2004","unstructured":"Stroev S.A.; Tjulkova E.I.; Gluschenko T.S.; Rybnikova E.A.; Samoilov M.O.; Pelto-Huikko M.; The augmentation of brain thioredoxin-1 expression after severe hypobaric hypoxia by the preconditioning in rats. Neurosci Lett 2004,370(2-3),224-229","journal-title":"Neurosci Lett"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11055-008-9091-5","volume":"39","author":"Stroev S.A.","year":"2009","unstructured":"Stroev S.A.; Tyul\u2019kova E.I.; Glushchenko T.S.; Tugoi I.A.; Samoilov M.O.; Pelto-Huikko M.; Thioredoxin-1 expression levels in rat hippocampal neurons in moderate hypobaric hypoxia. Neurosci Behav Physiol 2009,39(1),1-5","journal-title":"Neurosci Behav Physiol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.brainres.2012.09.024","volume":"1484","author":"Bendix I.","year":"2012","unstructured":"Bendix I.; Weichelt U.; Strasser K.; Serdar M.; Endesfelder S.; von Haefen C.; Heumann R.; Ehrkamp A.; Felderhoff-Mueser U.; Sifringer M.; Hyperoxia changes the balance of the thioredoxin\/peroxiredoxin system in the neonatal rat brain. Brain Res 2012,1484,68-75","journal-title":"Brain Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2016.02.043","volume":"363","author":"Dai J.X.","year":"2016","unstructured":"Dai J.X.; Cai J.Y.; Lin Q.; Chen X.D.; Lu C.; Sun J.; Ba H.J.; Thioredoxin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. J Neurol Sci 2016,363,84-89","journal-title":"J Neurol Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cca.2016.01.010","volume":"455","author":"Qian S.Q.","year":"2016","unstructured":"Qian S.Q.; Hu X.C.; He S.R.; Li B.B.; Zheng X.D.; Pan G.H.; Prognostic value of serum thioredoxin concentrations after intracerebral hemorrhage. Clin Chim Acta 2016,455,15-19","journal-title":"Clin Chim Acta"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3109\/10715762.2013.778403","volume":"47","author":"Shang H.","year":"2013","unstructured":"Shang H.; Yang D.; Zhang W.; Li T.; Ren X.; Wang X.; Zhao W.; Time course of Keap1-Nrf2 pathway expression after experimental intracerebral haemorrhage: Correlation with brain oedema and neurological deficit. Free Radic Res 2013,47(5),368-375","journal-title":"Free Radic Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/01616412.2015.1105626","volume":"38","author":"Erdi F.","year":"2016","unstructured":"Erdi F.; Keskin F.; Esen H.; Kaya B.; Feyzioglu B.; Kilinc I.; Karatas Y.; Cuce G.; Kalkan E.; Telmisartan ameliorates oxidative stress and subarachnoid haemorrhage-induced cerebral vasospasm. Neurol Res 2016,38(3),224-231","journal-title":"Neurol Res"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.apmr.2010.05.017","volume":"91","author":"Menon D.K.","year":"2010","unstructured":"Menon D.K.; Schwab K.; Wright D.W.; Maas A.I.; Position statement: Definition of traumatic brain injury. Arch Phys Med Rehabil 2010,91(11),1637-1640","journal-title":"Arch Phys Med Rehabil"},{"key":"ref=115","first-page":"1","volume":"130","author":"Dewan M.C.","year":"2018","unstructured":"Dewan M.C.; Rattani A.; Gupta S.; Baticulon R.E.; Hung Y-C.; Punchak M.; Agrawal A.; Adeleye A.O.; Shrime M.G.; Rubiano A.M.; Rosenfeld J.V.; Park K.B.; Estimating the global incidence of traumatic brain injury. J Neurosurg 2018,130(4),1-18","journal-title":"J Neurosurg"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","year":"2019","unstructured":"Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol GBD 2016 Neurology Collaborators2019,18(5),459-480","journal-title":"Lancet Neurol"},{"key":"ref=117","author":"Faul M.","year":"2010","unstructured":"Faul M.; Xu L.; Wald M.M.; Coronado V.G.; Emergency department visits, hospitalizations and deaths 2002-2006. Atlanta (GA): Centers for Disease control and prevention, national center for injury prevention and control. Available From: 2010"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","volume":"7","author":"Maas A.I.R.","year":"2008","unstructured":"Maas A.I.R.; Stocchetti N.; Bullock R.; Moderate and severe traumatic brain injury in adults. Lancet Neurol 2008,7(8),728-741","journal-title":"Lancet Neurol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"Ng S.Y.","year":"2019","unstructured":"Ng S.Y.; Lee A.Y.W.; Traumatic brain injuries: Pathophysiology and potential therapeutic targets. Front Cell Neurosci 2019,13,528","journal-title":"Front Cell Neurosci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1523\/JNEUROSCI.15-10-06747.1995","volume":"15","author":"Lippoldt A.","year":"1995","unstructured":"Lippoldt A.; Padilla C.A.; Gerst H.; Andbjer B.; Richter E.; Holmgren A.; Fuxe K.; Localization of thioredoxin in the rat brain and functional implications. J Neurosci 1995,15(10),6747-6756","journal-title":"J Neurosci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0169-328X(98)00244-7","volume":"62","author":"Mansur K.","year":"1998","unstructured":"Mansur K.; Iwahashi Y.; Kiryu-Seo S.; Su Q.; Namikawa K.; Yodoi J.; Kiyama H.; Up-regulation of thioredoxin expression in motor neurons after nerve injury. Brain Res Mol Brain Res 1998,62(1),86-91","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.10.014","volume":"1306","author":"Hama I.","year":"2010","unstructured":"Hama I.; Nakagomi S.; Konishi H.; Kiyama H.; Simultaneous expression of glutathione, thioredoxin-1, and their reductases in nerve transected hypoglossal motor neurons of rat. Brain Res 2010,1306,1-7","journal-title":"Brain Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8460290","volume":"2019","author":"Cong P.","year":"2019","unstructured":"Cong P.; Tong C.; Liu Y.; Shi L.; Shi X.; Zhao Y.; Xiao K.; Jin H.; Liu Y.; Hou M.; CD28 deficiency ameliorates thoracic blast exposure-induced oxidative stress and apoptosis in the brain through the PI3K\/Nrf2\/Keap1 signaling pathway. Oxid Med Cell Longev 2019,2019,1-14","journal-title":"Oxid Med Cell Longev"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2147\/NDT.S266136","volume":"16","author":"Niu F.","year":"2020","unstructured":"Niu F.; Qian K.; Qi H.; Zhao Y.; Jiang Y.; Jia W.; Sun M.; CPCGI reduces gray and white matter injury by upregulating Nrf2 signaling and suppressing calpain overactivation in a rat model of controlled cortical impact. Neuropsychiatr Dis Treat 2020,16,1929-1941","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cca.2015.11.030","volume":"453","author":"Pan D.S.","year":"2016","unstructured":"Pan D.S.; Le H.W.; Yan M.; Hassan M.; Gong J.B.; Wang H.; Change of serum levels of thioredoxin in patients with severe traumatic brain injury. Clin Chim Acta 2016,453,62-66","journal-title":"Clin Chim Acta"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cca.2017.03.024","volume":"469","author":"Dong X.Q.","year":"2017","unstructured":"Dong X.Q.; Yu W.H.; Zhang Z.Y.; Yang D.B.; Du Q.; Wang H.; Shen Y.F.; Jiang L.; Che Z.H.; Zhu Q.; Serum thioredoxin and in-hospital major adverse events after traumatic brain injury. Clin Chim Acta 2017,469,75-80","journal-title":"Clin Chim Acta"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1089\/neu.2011.1806","volume":"29","author":"Hatic H.","year":"2012","unstructured":"Hatic H.; Kane M.J.; Saykally J.N.; Citron B.A.; Modulation of transcription factor Nrf2 in an in vitro model of traumatic brain injury. J Neurotrauma 2012,29(6),1188-1196","journal-title":"J Neurotrauma"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1667\/RR13753.1","volume":"182","author":"Allen A.R.","year":"2014","unstructured":"Allen A.R.; Eilertson K.; Sharma S.; Baure J.; Allen B.; Leu D.; Rosi S.; Raber J.; Huang T.T.; Fike J.R.; Delayed administration of alpha-difluoromethylornithine prevents hippocampus-dependent cognitive impairment after single and combined injury in mice. Radiat Res 2014,182(5),489-498","journal-title":"Radiat Res"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s11064-017-2340-7","volume":"42","author":"Chen T.","year":"2017","unstructured":"Chen T.; Wu Y.; Wang Y.; Zhu J.; Chu H.; Kong L.; Yin L.; Ma H.; Brain-derived neurotrophic factor increases synaptic protein levels via the MAPK\/Erk signaling pathway and Nrf2\/Trx axis following the transplantation of neural stem cells in a rat model of traumatic brain injury. Neurochem Res 2017,42(11),3073-3083","journal-title":"Neurochem Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"e0157064","DOI":"10.1371\/journal.pone.0157064","volume":"11","author":"Baratz-Goldstein R.","year":"2016","unstructured":"Baratz-Goldstein R.; Deselms H.; Heim L.R.; Khomski L.; Hoffer B.J.; Atlas D.; Pick C.G.; Thioredoxin-mimetic-peptides protect cognitive function after mild traumatic brain injury (mTBI). PLoS One 2016,11(6),e0157064","journal-title":"PLoS One"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"e0210670","DOI":"10.1371\/journal.pone.0210670","volume":"14","author":"Yu J.T.","year":"2019","unstructured":"Yu J.T.; Liu Y.; Dong P.; Cheng R.E.; Ke S.X.; Chen K.Q.; Wang J.J.; Shen Z.S.; Tang Q.Y.; Zhang Z.; Up-regulation of antioxidative proteins TRX1, TXNL1 and TXNRD1 in the cortex of PTZ kindling seizure model mice. PLoS One 2019,14(1),e0210670","journal-title":"PLoS One"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"Coyle J.T.","year":"1993","unstructured":"Coyle J.T.; Puttfarcken P.; Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993,262(5134),689-695","journal-title":"Science"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/00001756-199405000-00009","volume":"5","author":"Pollard H.","year":"1994","unstructured":"Pollard H.; Cantagrel S.; Charriaut-Marlangue C.; Moreau J.; Ari Y.B.; Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport 1994,5(9),1053-1055","journal-title":"Neuroreport"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neulet.2004.02.013","volume":"359","author":"Yalcin A.","year":"2004","unstructured":"Yalcin A.; Kanit L.; Sozmen E.Y.; Altered gene expressions in rat hippocampus after kainate injection with or without melatonin pre-treatment. Neurosci Lett 2004,359(1-2),65-68","journal-title":"Neurosci Lett"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/00004647-200005000-00009","volume":"20","author":"Takagi Y.","year":"2000","unstructured":"Takagi Y.; Hattori I.; Nozaki K.; Mitsui A.; Ishikawa M.; Hashimoto N.; Yodoi J.; Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice. J Cereb Blood Flow Metab 2000,20(5),829-833","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuint.2017.06.004","volume":"108","author":"Yang H.","year":"2017","unstructured":"Yang H.; Zhao N.; Lv L.; Yan X.; Hu S.; Xu T.; Functional research and molecular mechanism of Kainic acid-induced denitrosylation of thioredoxin-1 in rat hippocampus. Neurochem Int 2017,108,448-456","journal-title":"Neurochem Int"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/antiox10030357","volume":"10","author":"Trstenjak Prebanda M.","year":"2021","unstructured":"Trstenjak Prebanda M.; Matjan-\u0160tefin P.; Turk B.; Kopitar-Jerala N.; Altered expression of peroxiredoxins in mouse model of progressive myoclonus epilepsy upon LPS-Induced Neuroinflammation. Antioxidants 2021,10(3),357","journal-title":"Antioxidants"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/cells8121476","volume":"8","author":"Trstenjak Prebanda M.","year":"2019","unstructured":"Trstenjak Prebanda M.; Zavr\u0161nik J.; Turk B.; Kopitar Jerala N.; Upregulation of Mitochondrial Redox Sensitive Proteins in LPS-Treated Stefin B-Deficient Macrophages. Cells 2019,8(12),1476","journal-title":"Cells"},{"key":"ref=139","year":"2022","unstructured":"Alzheimer\u2019s Disease Facts and Figures. Alzheimer AssociationAvailable From: 2022"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"Holtzman D.M.","year":"2011","unstructured":"Holtzman D.M.; Morris J.C.; Goate A.M.; Alzheimer\u2019s disease: The challenge of the second century. Sci Transl Med 2011,3(77),77sr1","journal-title":"Sci Transl Med"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","volume":"56","author":"Castellani R.J.","year":"2010","unstructured":"Castellani R.J.; Rolston R.K.; Smith M.A.; Alzheimer Disease. Dis Mon 2010,56(9),484-546","journal-title":"Dis Mon"},{"key":"ref=142","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-5416-4_1","author":"Harris J.R.","year":"2012","unstructured":"Harris J.R.;  Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease \n65.\n2012","journal-title":"Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"Lane C.A.","year":"2018","unstructured":"Lane C.A.; Hardy J.; Schott J.M.; Alzheimer\u2019s disease. Eur J Neurol 2018,25(1),59-70","journal-title":"Eur J Neurol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2010.03.085","volume":"1333","author":"Di Domenico F.","year":"2010","unstructured":"Di Domenico F.; Sultana R.; Tiu G.F.; Scheff N.N.; Perluigi M.; Cini C.; Butterfield D.A.; Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: An investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res 2010,1333,72-81","journal-title":"Brain Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s12031-015-0633-3","volume":"57","author":"Shah S.Z.A.","year":"2015","unstructured":"Shah S.Z.A.; Zhao D.; Khan S.H.; Yang L.; Unfolded protein response pathways in neurodegenerative diseases. J Mol Neurosci 2015,57(4),529-537","journal-title":"J Mol Neurosci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/nm1067","volume":"10","author":"Bossy-Wetzel E.","year":"2004","unstructured":"Bossy-Wetzel E.; Schwarzenbacher R.; Lipton S. A.; Molecular pathways to neurodegeneration. Nat Med 2004,10,S2-9","journal-title":"Nat Med"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"T\u00f6nnies E.","year":"2017","unstructured":"T\u00f6nnies E.; Trushina E.; Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis 2017,57(4),1105-1121","journal-title":"J Alzheimers Dis"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fnagi.2015.00124","volume":"7","author":"von Bernhardi R.","year":"2015","unstructured":"von Bernhardi R.; Eugen\u00edn-von Bernhardi L.; Eugen\u00edn J.; Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci 2015,7,124","journal-title":"Front Aging Neurosci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1089\/ars.2017.7440","volume":"30","author":"Wang C.Y.","year":"2019","unstructured":"Wang C.Y.; Xu Y.; Wang X.; Guo C.; Wang T.; Wang Z.Y.; Dl-3-n-butylphthalide inhibits NLRP3 inflammasome and mitigates Alzheimer\u2019s-like pathology via Nrf2-TXNIP-TrX axis. Antioxid Redox Signal 2019,30(11),1411-1431","journal-title":"Antioxid Redox Signal"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1089\/ars.2021.0186","volume":"36","author":"Awan M.U.N.","year":"2022","unstructured":"Awan M.U.N.; Yan F.; Mahmood F.; Bai L.; Liu J.; Bai J.; The functions of thioredoxin 1 in neurodegeneration. Antioxid Redox Signal 2022,36(13-15),1023-1036","journal-title":"Antioxid Redox Signal"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"Uttara B.","year":"2009","unstructured":"Uttara B.; Singh A.; Zamboni P.; Mahajan R.; Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009,7(1),65-74","journal-title":"Curr Neuropharmacol"},{"key":"ref=152","doi-asserted-by":"publisher","DOI":"10.1177\/1759091421994351","volume":"13","author":"Jia J.","year":"2021","unstructured":"Jia J.; Zeng X.; Xu G.; Wang Z.; The potential roles of redox enzymes in Alzheimer\u2019s Disease: Focus on thioredoxin. ASN Neuro 2021,13","journal-title":"ASN Neuro"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1089\/ars.2016.6860","volume":"27","author":"Ahmad F.","year":"2017","unstructured":"Ahmad F.; Singh K.; Das D.; Gowaikar R.; Shaw E.; Ramachandran A.; Rupanagudi K.V.; Kommaddi R.P.; Bennett D.A.; Ravindranath V.; Reactive oxygen species-mediated loss of synaptic Akt1 signaling leads to deficient activity-dependent protein translation early in Alzheimer\u2019s disease. Antioxid Redox Signal 2017,27(16),1269-1280","journal-title":"Antioxid Redox Signal"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3233\/JAD-2010-100960","volume":"22","author":"Ellis G.","year":"2010","unstructured":"Ellis G.; Fang E.; Maheshwari M.; Roltsch E.; Holcomb L.; Zimmer D.; Martinez D.; Murray I.V.J.; Lipid oxidation and modification of amyloid-\u03b2 (A\u03b2) in vitro and in vivo. J Alzheimers Dis 2010,22(2),593-607","journal-title":"J Alzheimers Dis"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JAD-2011-101425","volume":"24","author":"Sultana R.","year":"2011","unstructured":"Sultana R.; Mecocci P.; Mangialasche F.; Cecchetti R.; Baglioni M.; Butterfield D.A.; Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer\u2019s disease: Insights into the role of oxidative stress in Alzheimer\u2019s disease and initial investigations into a potential biomarker for this dementing disorder. J Alzheimers Dis 2011,24(1),77-84","journal-title":"J Alzheimers Dis"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neurobiolaging.2004.07.016","volume":"26","author":"Migliore L.","year":"2005","unstructured":"Migliore L.; Fontana I.; Trippi F.; Colognato R.; Copped\u00e8 F.; Tognoni G.; Nucciarone B.; Siciliano G.; Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 2005,26(5),567-573","journal-title":"Neurobiol Aging"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JAD-131814","volume":"39","author":"Arodin L.","year":"2014","unstructured":"Arodin L.; Lamparter H.; Karlsson H.; Nennesmo I.; Bj\u00f6rnstedt M.; Schr\u00f6der J.; Fernandes A.P.; Alteration of thioredoxin and glutaredoxin in the progression of Alzheimer\u2019s disease. J Alzheimers Dis 2014,39(4),787-797","journal-title":"J Alzheimers Dis"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0891-5849(99)00258-0","volume":"28","author":"Lovell M.A.","year":"2000","unstructured":"Lovell M.A.; Xie C.; Gabbita S.P.; Markesbery W.R.; Decreased thioredoxin and increased thioredoxin reductase levels in alzheimer\u2019s disease brain. Free Radic Biol Med 2000,28(3),418-427","journal-title":"Free Radic Biol Med"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1089\/ars.2019.7754","volume":"31","author":"Kommaddi R.P.","year":"2019","unstructured":"Kommaddi R.P.; Tomar D.S.; Karunakaran S.; Bapat D.; Nanguneri S.; Ray A.; Schneider B.L.; Nair D.; Ravindranath V.; Glutaredoxin1 diminishes amyloid beta-mediated oxidation of F-actin and reverses cognitive deficits in an Alzheimer\u2019s disease mouse model. Antioxid Redox Signal 2019,31(18),1321-1338","journal-title":"Antioxid Redox Signal"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-4933-10-41","volume":"10","author":"Cornelius C.","year":"2013","unstructured":"Cornelius C.; Trovato Salinaro A.; Scuto M.; Fronte V.; Cambria M.T.; Pennisi M.; Bella R.; Milone P.; Graziano A.; Crupi R.; Cuzzocrea S.; Pennisi G.; Calabrese V.; Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: Role of vitagenes. Immun Ageing 2013,10(1),41","journal-title":"Immun Ageing"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"104685","DOI":"10.1016\/j.neuint.2020.104685","volume":"135","author":"Pan Q.","year":"2020","unstructured":"Pan Q.; Guo K.; Xue M.; Tu Q.; Estrogen protects neuroblastoma cell from amyloid-\u03b2 42 (A\u03b242)-induced apoptosis via TXNIP\/TRX axis and AMPK signaling. Neurochem Int 2020,135,104685","journal-title":"Neurochem Int"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JAD-190223","volume":"72","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Wang Y.; Bharti V.; Zhou H.; Hoi V.; Tan H.; Wu Z.; Nagakannan P.; Eftekharpour E.; Wang J.F.; Upregulation of thioredoxin-interacting protein in brain of amyloid-\u03b2 protein precursor\/presenilin 1 transgenic mice and amyloid-\u03b2 treated neuronal cells. J Alzheimers Dis 2019,72(1),139-150","journal-title":"J Alzheimers Dis"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/ars.2011.4137","volume":"16","author":"Spindel O.N.","year":"2012","unstructured":"Spindel O.N.; World C.; Berk B.C.; Thioredoxin interacting protein: Redox dependent and independent regulatory mechanisms. Antioxid Redox Signal 2012,16(6),587-596","journal-title":"Antioxid Redox Signal"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41380-019-0521-2","volume":"26","author":"Gerenu G.","year":"2021","unstructured":"Gerenu G.; Persson T.; Goikolea J.; Calvo-Garrido J.; Loera-Valencia R.; Pottmeier P.; Santiago C.; Poska H.; Presto J.; Cedazo-Minguez A.; Thioredoxin-80 protects against amyloid-beta pathology through autophagic-lysosomal pathway regulation. Mol Psychiatry 2021,26(4),1410-1423","journal-title":"Mol Psychiatry"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"60","DOI":"10.18773\/austprescr.2015.018","volume":"38","author":"Waite L.","year":"2015","unstructured":"Waite L.; Treatment for Alzheimer\u2019s disease: Has anything changed? Aust Prescr 2015,38(2),60-63","journal-title":"Aust Prescr"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.3892\/mmr.2019.10010","volume":"19","author":"Chen Y.","year":"2019","unstructured":"Chen Y.; Shi G.W.; Liang Z.M.; Sheng S.Y.; Shi Y.S.; Peng L.; Wang Y.P.; Wang F.; Zhang X.M.; Resveratrol improves cognition and decreases amyloid plaque formation in Tg6799 mice. Mol Med Rep 2019,19(5),3783-3790","journal-title":"Mol Med Rep"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1385\/ENDO:21:1:27","volume":"21","author":"Chiueh C.C.","year":"2003","unstructured":"Chiueh C.C.; Lee S.Y.; Andoh T.; Murphy D.L.; Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocr J 2003,21(1),27-32","journal-title":"Endocr J"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbr.2015.06.045","volume":"293","author":"Gao J.","year":"2015","unstructured":"Gao J.; He H.; Jiang W.; Chang X.; Zhu L.; Luo F.; Zhou R.; Ma C.; Yan T.; Salidroside ameliorates cognitive impairment in a d-galactose-induced rat model of Alzheimer\u2019s disease. Behav Brain Res 2015,293,27-33","journal-title":"Behav Brain Res"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3892\/ijmm.2019.4088","volume":"43","author":"Liao Z.L.","year":"2019","unstructured":"Liao Z.L.; Su H.; Tan Y.F.; Qiu Y.J.; Zhu J.P.; Chen Y.; Lin S.S.; Wu M.H.; Mao Y.P.; Hu J.J.; Yu E.Y.; Salidroside protects PC-12 cells against amyloid \u03b2-induced apoptosis by activation of the ERK1\/2 and AKT signaling pathways. Int J Mol Med 2019,43(4),1769-1777","journal-title":"Int J Mol Med"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neulet.2011.11.016","volume":"506","author":"Mateos L.","year":"2012","unstructured":"Mateos L.; Persson T.; Kathozi S.; Gil-Bea F.J.; Cedazo-Minguez A.; Estrogen protects against amyloid-\u03b2 toxicity by estrogen receptor \u03b1-mediated inhibition of Daxx translocation. Neurosci Lett 2012,506(2),245-250","journal-title":"Neurosci Lett"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1089\/dna.2018.4308","volume":"38","author":"Feng L.","year":"2019","unstructured":"Feng L.; Zhang L.; Resveratrol suppresses A\u03b2-induced microglial activation through the TXNIP\/TRX\/NLRP3 signaling pathway. DNA Cell Biol 2019,38(8),874-879","journal-title":"DNA Cell Biol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11064-017-2421-7","volume":"43","author":"Hui Y.","year":"2018","unstructured":"Hui Y.; Chengyong T.; Cheng L.; Haixia H.; Yuanda Z.; Weihua Y.; Resveratrol attenuates the cytotoxicity induced by amyloid-\u03b2 in PC12 cells by upregulating heme oxygenase-1 via the PI3K\/Akt\/Nrf2 pathway. Neurochem Res 2018,43(2),297-305","journal-title":"Neurochem Res"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s10571-020-00801-w","volume":"40","author":"Wang H.","year":"2020","unstructured":"Wang H.; Li Q.; Sun S.; Chen S.; Neuroprotective effects of salidroside in a mouse model of Alzheimer\u2019s disease. Cell Mol Neurobiol 2020,40(7),1133-1142","journal-title":"Cell Mol Neurobiol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fnagi.2019.00242","volume":"11","author":"Marongiu R.","year":"2019","unstructured":"Marongiu R.; Accelerated ovarian failure as a unique model to study peri-menopause influence on Alzheimer\u2019s disease. Front Aging Neurosci 2019,11,242","journal-title":"Front Aging Neurosci"},{"key":"ref=175","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12432","volume":"28","author":"Duarte A.C.","year":"2016","unstructured":"Duarte A.C.; Hrynchak M.V.; Gon\u00e7alves I.; Quintela T.; Santos C.R.A.; Sex hormone decline and amyloid \u03b2 synthesis, transport and clearance in the brain. J Neuroendocrinol 2016,28(11)","journal-title":"J Neuroendocrinol"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s11011-016-9814-1","volume":"31","author":"Zhuo Y.","year":"2016","unstructured":"Zhuo Y.; Guo H.; Cheng Y.; Wang C.; Wang C.; Wu J.; Zou Z.; Gan D.; Li Y.; Xu J.; Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by A\u03b225\u201335 in rats. Metab Brain Dis 2016,31(4),779-791","journal-title":"Metab Brain Dis"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/781938","volume":"2015","author":"Masci A.","year":"2015","unstructured":"Masci A.; Mattioli R.; Costantino P.; Baima S.; Morelli G.; Punzi P.; Giordano C.; Pinto A.; Donini L.M.; d\u2019Erme M.; Mosca L.; Neuroprotective effect of Brassica oleracea sprouts crude juice in a cellular model of Alzheimer\u2019s disease. Oxid Med Cell Longev 2015,2015,1-17","journal-title":"Oxid Med Cell Longev"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3233\/JAD-150738","volume":"56","author":"Persson T.","year":"2017","unstructured":"Persson T.; Lattanzio F.; Calvo-Garrido J.; Rimondini R.; Rubio-Rodrigo M.; Sundstr\u00f6m E.; Maioli S.; Sandebring-Matton A.; Cedazo-M\u00ednguez \u00c1.; Apolipoprotein E4 elicits lysosomal cathepsin D release, decreased thioredoxin-1 levels, and apoptosis. J Alzheimers Dis 2017,56(2),601-617","journal-title":"J Alzheimers Dis"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"Dauer W.","year":"2003","unstructured":"Dauer W.; Przedborski S.; Parkinson\u2019s disease. Neuron 2003,39(6),889-909","journal-title":"Neuron"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1093\/hmg\/ddq167","volume":"19","author":"Cookson M.R.","year":"2010","unstructured":"Cookson M.R.; Bandmann O.; Parkinson\u2019s disease: Insights from pathways. Hum Mol Genet 2010,19(R1),R21-R27","journal-title":"Hum Mol Genet"},{"key":"ref=181","first-page":"57","volume":"44","author":"Jenner P.","year":"1996","unstructured":"Jenner P.; Oxidative stress in Parkinson\u2019s disease and other neurodegenerative disorders. Pathol Biol (Paris) 1996,44(1),57-64","journal-title":"Pathol Biol (Paris)"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1212\/WNL.66.10_suppl_4.S24","volume":"66","author":"Jenner P.","year":"2006","unstructured":"Jenner P.; Olanow C.W.; The pathogenesis of cell death in Parkinson\u2019s disease. Neurology 2006,66(10)(Suppl. 4),S24-S36","journal-title":"Neurology"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"Lang A.E.","year":"1998","unstructured":"Lang A.E.; Lozano A.M.; Parkinson\u2019s Disease. N Engl J Med 1998,339(15),1044-1053","journal-title":"N Engl J Med"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"Parker W.D.","year":"2008","unstructured":"Parker W.D.; Parks J.K.; Swerdlow R.H.; Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res 2008,1189,215-218","journal-title":"Brain Res"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1001\/jama.286.18.2239","volume":"286","author":"Scott W.K.","year":"2001","unstructured":"Scott W.K.; Nance M.A.; Watts R.L.; Hubble J.P.; Koller W.C.; Lyons K.; Pahwa R.; Stern M.B.; Colcher A.; Hiner B.C.; Jankovic J.; Ondo W.G.; Allen F.H.; Goetz C.G.; Small G.W.; Masterman D.; Mastaglia F.; Laing N.G.; Stajich J.M.; Slotterbeck B.; Booze M.W.; Ribble R.C.; Rampersaud E.; West S.G.; Gibson R.A.; Middleton L.T.; Roses A.D.; Haines J.L.; Scott B.L.; Vance J.M.; Pericak-Vance M.A.; Complete genomic screen in Parkinson disease: Evidence for multiple genes. JAMA 2001,286(18),2239-2244","journal-title":"JAMA"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1007\/s12035-016-0147-1","volume":"54","author":"Cunha M.P.","year":"2017","unstructured":"Cunha M.P.; Pazini F.L.; Lieberknecht V.; Budni J.; Oliveira \u00c1.; Rosa J.M.; Mancini G.; Mazzardo L.; Colla A.R.; Leite M.C.; Santos A.R.S.; Martins D.F.; de Bem A.F.; Gon\u00e7alves C.A.S.; Farina M.; Rodrigues A.L.S.; MPP-Lesioned mice: An experimental model of motor, emotional, memory\/learning, and striatal neurochemical dysfunctions. Mol Neurobiol 2017,54(8),6356-6377","journal-title":"Mol Neurobiol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0006-8993(96)01271-1","volume":"749","author":"Sriram K.","year":"1997","unstructured":"Sriram K.; Pai K.S.; Boyd M.R.; Ravindranath V.; Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice. Brain Res 1997,749(1),44-52","journal-title":"Brain Res"},{"key":"ref=188","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000407513","volume":"19","author":"Birkmayer W.","year":"1983","unstructured":"Birkmayer W.; Knoll J.; Riederer P.; Youdim M.B.H.; (-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. Mod Probl Pharmacopsychiatry 1983,19,170-6","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"Burns R.S.","year":"1983","unstructured":"Burns R.S.; Chiueh C.C.; Markey S.P.; Ebert M.H.; Jacobowitz D.M.; Kopin I.J.; A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983,80(14),4546-4550","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/j.1471-4159.1985.tb10556.x","volume":"45","author":"Mytilineou C.","year":"1985","unstructured":"Mytilineou C.; Cohen G.; Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. J Neurochem 1985,45(6),1951-1953","journal-title":"J Neurochem"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1124\/mol.105.012302","volume":"68","author":"Andoh T.","year":"2005","unstructured":"Andoh T.; Chock P.B.; Murphy D.L.; Chiueh C.C.; Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl. Mol Pharmacol 2005,68(5),1408-1414","journal-title":"Mol Pharmacol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1021\/acschemneuro.7b00247","volume":"9","author":"Li Q.","year":"2018","unstructured":"Li Q.; Niu C.; Zhang X.; Dong M.; Gastrodin and isorhynchophylline synergistically inhibit MPP-induced oxidative stress in SH-SY5Y cells by targeting ERK1\/2 and GSK-3\u03b2 pathways: Involvement of Nrf2 nuclear translocation. ACS Chem Neurosci 2018,9(3),482-493","journal-title":"ACS Chem Neurosci"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jep.2010.10.017","volume":"133","author":"Luo F.C.","year":"2011","unstructured":"Luo F.C.; Wang S.D.; Qi L.; Song J.Y.; Lv T.; Bai J.; Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. J Ethnopharmacol 2011,133(2),448-453","journal-title":"J Ethnopharmacol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0891-5849(98)00200-7","volume":"26","author":"Kojima S.","year":"1999","unstructured":"Kojima S.; Matsuki O.; Nomura T.; Yamaoka K.; Takahashi M.; Niki E.; Elevation of antioxidant potency in the brain of mice by low-dose \u03b3-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced brain damage. Free Radic Biol Med 1999,26(3-4),388-395","journal-title":"Free Radic Biol Med"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/bs.irn.2017.05.018","volume":"133","author":"Titova N.","year":"2017","unstructured":"Titova N.; Schapira A.H.V.; Chaudhuri K.R.; Qamar M.A.; Katunina E.; Jenner P.; Nonmotor symptoms in experimental models of Parkinson\u2019s disease. Int Rev Neurobiol 2017,133,63-89","journal-title":"Int Rev Neurobiol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.freeradbiomed.2018.06.029","volume":"124","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Bai L.; Zhang S.; Zhou X.; Li Y.; Bai J.; Trx-1 ameliorates learning and memory deficits in MPTP-induced Parkinson\u2019s disease model in mice. Free Radic Biol Med 2018,124,380-387","journal-title":"Free Radic Biol Med"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.275.5296.90","volume":"275","author":"Ichijo H.","year":"1997","unstructured":"Ichijo H.; Nishida E.; Irie K.; Dijke P.; Saitoh M.; Moriguchi T.; Takagi M.; Matsumoto K.; Miyazono K.; Gotoh Y.; Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways. Science 1997,275(5296),90-94","journal-title":"Science"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","volume":"17","author":"Saitoh M.","year":"1998","unstructured":"Saitoh M.; Nishitoh H.; Fujii M.; Takeda K.; Tobiume K.; Sawada Y.; Kawabata M.; Miyazono K.; Ichijo H.; Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998,17(9),2596-2606","journal-title":"EMBO J"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2015.06.041","volume":"87","author":"Ray A.","year":"2015","unstructured":"Ray A.; Sehgal N.; Karunakaran S.; Rangarajan G.; Ravindranath V.; MPTP activates ASK1\u2013p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model. Free Radic Biol Med 2015,87,312-325","journal-title":"Free Radic Biol Med"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"Bonifati V.","year":"2003","unstructured":"Bonifati V.; Rizzu P.; van Baren M.J.; Schaap O.; Breedveld G.J.; Krieger E.; Dekker M.C.J.; Squitieri F.; Ibanez P.; Joosse M.; van Dongen J.W.; Vanacore N.; van Swieten J.C.; Brice A.; Meco G.; van Duijn C.M.; Oostra B.A.; Heutink P.; Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003,299(5604),256-259","journal-title":"Science"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1093\/hmg\/ddg304","volume":"12","author":"Macedo M.G.","year":"2003","unstructured":"Macedo M.G.; Anar B.; Bronner I.F.; Cannella M.; Squitieri F.; Bonifati V.; Hoogeveen A.; Heutink P.; Rizzu P.; The DJ-1L166P mutant protein associated with early onset Parkinson\u2019s disease is unstable and forms higher-order protein complexes. Hum Mol Genet 2003,12(21),2807-2816","journal-title":"Hum Mol Genet"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/j.1471-4159.2003.02265.x","volume":"87","author":"Moore D.J.","year":"2003","unstructured":"Moore D.J.; Zhang L.; Dawson T.M.; Dawson V.L.; A missense mutation (L166P) in DJ-1, linked to familial Parkinson\u2019s disease, confers reduced protein stability and impairs homo-oligomerization. J Neurochem 2003,87(6),1558-1567","journal-title":"J Neurochem"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"Bandopadhyay R.","year":"2004","unstructured":"Bandopadhyay R.; Kingsbury A.E.; Cookson M.R.; Reid A.R.; Evans I.M.; Hope A.D.; Pittman A.M.; Lashley T.; Canet-Aviles R.; Miller D.W.; McLendon C.; Strand C.; Leonard A.J.; Abou-Sleiman P.M.; Healy D.G.; Ariga H.; Wood N.W.; de Silva R.; Revesz T.; Hardy J.A.; Lees A.J.; The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 2004,127(2),420-430","journal-title":"Brain"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neures.2010.04.002","volume":"67","author":"Im J.Y.","year":"2010","unstructured":"Im J.Y.; Lee K.W.; Junn E.; Mouradian M.M.; DJ-1 protects against oxidative damage by regulating the thioredoxin\/ASK1 complex. Neurosci Res 2010,67(3),203-208","journal-title":"Neurosci Res"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1550-8579(07)80003-9","volume":"4","author":"Shulman L.M.","year":"2007","unstructured":"Shulman L.M.; Gender differences in Parkinson\u2019s disease. Gend Med 2007,4(1),8-18","journal-title":"Gend Med"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12640-009-9058-5","volume":"16","author":"Saeed U.","year":"2009","unstructured":"Saeed U.; Karunakaran S.; Meka D.P.; Koumar R.C.; Ramakrishnan S.; Joshi S.D.; Nidadavolu P.; Ravindranath V.; Redox activated MAP kinase death signaling cascade initiated by ASK1 is not activated in female mice following MPTP: Novel mechanism of neuroprotection. Neurotox Res 2009,16(2),116-126","journal-title":"Neurotox Res"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajim.4700170307","volume":"17","author":"Hertzman C.","year":"1990","unstructured":"Hertzman C.; Wiens M.; Bowering D.; Snow B.; Calne D.; Parkinson\u2019s disease: A case-control study of occupational and environmental risk factors. Am J Ind Med 1990,17(3),349-355","journal-title":"Am J Ind Med"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1074\/jbc.M708451200","volume":"283","author":"Fei Q.","year":"2008","unstructured":"Fei Q.; McCormack A.L.; Di Monte D.A.; Ethell D.W.; Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J Biol Chem 2008,283(6),3357-3364","journal-title":"J Biol Chem"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/15287390701738467","volume":"71","author":"Yang W.","year":"2008","unstructured":"Yang W.; Tiffany-Castiglioni E.; Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: Involvement of p53 and mitochondria. J Toxicol Environ Health A 2008,71(4),289-299","journal-title":"J Toxicol Environ Health A"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.freeradbiomed.2010.02.024","volume":"48","author":"Niso-Santano M.","year":"2010","unstructured":"Niso-Santano M.; Gonz\u00e1lez-Polo R.A.; Bravo-San Pedro J.M.; G\u00f3mez-S\u00e1nchez R.; Lastres-Becker I.; Ortiz-Ortiz M.A.; Soler G.; Mor\u00e1n J.M.; Cuadrado A.; Fuentes J.M.; Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: Modulation by the Nrf2\/Trx axis. Free Radic Biol Med 2010,48(10),1370-1381","journal-title":"Free Radic Biol Med"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-10-4","volume":"10","author":"Chen Y.","year":"2015","unstructured":"Chen Y.; Zhang D.; Liao Z.; Wang B.; Gong S.; Wang C.; Zhang M.; Wang G.; Cai H.; Liao F.F.; Xu J.; Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson\u2019s disease. Mol Neurodegener 2015,10(1),4","journal-title":"Mol Neurodegener"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1523\/JNEUROSCI.4589-10.2011","volume":"31","author":"Hu X.","year":"2011","unstructured":"Hu X.; Weng Z.; Chu C.T.; Zhang L.; Cao G.; Gao Y.; Signore A.; Zhu J.; Hastings T.; Greenamyre J.T.; Chen J.; Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci 2011,31(1),247-261","journal-title":"J Neurosci"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1002\/ams2.696","volume":"8","author":"Bsat S.","year":"2021","unstructured":"Bsat S.; Halaoui A.; Kobeissy F.; Moussalem C.; El Houshiemy M.N.; Kawtharani S.; Omeis I.; Acute ischemic stroke biomarkers: A new era with diagnostic promise? Acute Med Surg 2021,8(1),e696","journal-title":"Acute Med Surg"},{"key":"ref=214","doi-asserted-by":"crossref","first-page":"19","DOI":"10.35584\/carejournal.v1i1.3","volume":"1","author":"Findlay M.C.","year":"2022","unstructured":"Findlay M.C.; Bauer S.Z.; Gautam D.; Lucke-Wold B.; Rehabilitation After Neurotrauma: A Commentary. J Surg Care 2022,1(1),19-26","journal-title":"J Surg Care"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205020666230809145041","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219594\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205020666230809145041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T11:14:06Z","timestamp":1699442046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219594\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":214,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205020666230809145041","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}